Simultaneous targeting therapy for lung metastasis and breast tumor by blocking the NF-κB signaling pathway using Celastrol-loaded micelles

References

• Aggarwal S, Das SN. (2016). Garcinol inhibits tumour cell proliferation, angiogenesis, cell cycle progression and induces apoptosis via NF-kappa B inhibition in oral cancer. Tumor Biol 37:7175–84.
   PubMedGoogle Scholar
• Ahmed M, Douek M. (2013). The role of magnetic nanoparticles in the localization and treatment of breast cancer. Biomed Res Int 2013:281–30.
   Web of Science ®Google Scholar
• Bergh JJ, Lin HY, Lansing L, et al. (2005). Integrin alphaVbeta3 contains a cell surface receptor site for thyroid hormone that is linked to activation of mitogen-activated protein kinase and induction of angiogenesis. Endocrinology 146:2864–71.
   PubMed Web of Science ®Google Scholar
• Bonotto M, Gerratana L, Poletto E, et al. (2014). Measures of outcome in metastatic breast cancer: insights from a real-world scenario. Oncologist 19:608–15.
   PubMed Web of Science ®Google Scholar
• Danhier F, Le Breton A, Preat V. (2012). RGD-based strategies to target alpha(v) beta(3) integrin in cancer therapy and diagnosis. Mol Pharmaceutics 9:2961–73.
   PubMed Web of Science ®Google Scholar
• Du YZ, Cai LL, Liu P, You J, et al.. (2012). Tumor cells-specific targeting delivery achieved by A54 peptide functionalized polymeric micelles. Biomaterials 33:8858–67.
   PubMed Web of Science ®Google Scholar
• Ducommun B, Lobjois V. (2014). Multicellular tumor spheroid 3D models to decipher cancer cell biology and to evaluate anticancer drugs. Cancer Res 74(19 Suppl):Abstract nr 2025.
   Web of Science ®Google Scholar
• Heerboth S, Housman G, Leary M, et al. (2015). EMT and tumor metastasis. Clin Trans Med 4:6.
   PubMed Web of Science ®Google Scholar
• Hood JD, Cheresh DA. (2002). Role of integrins in cell invasion and migration. Nat Rev Cancer 2:91–100.
   PubMed Web of Science ®Google Scholar
• Huang LL, Zhang ZF, Zhang S, Ren JH, et al. (2011). Inhibitory action of Celastrol on hypoxia-mediated angiogenesis and metastasis via the HIF-1 alpha pathway. Int J Mol Med 27:407–15.
   PubMed Web of Science ®Google Scholar
• Huang S, DeGuzman A, Bucana CD, Fidler IJ. (2000). Nuclear factor-kappa B activity correlates with growth, angiogenesis, and metastasis of human melanoma cells in nude mice. ClinCancer Res 6:2573–81.
   Google Scholar
• Kang CM, Koo HJ, Lee S, et al. (2013). 64Cu-Labeled tetraiodothyroacetic acid-conjugated liposomes for PET imaging of tumor angiogenesis. Nucl Med Biol 40:1018–24.
   PubMed Web of Science ®Google Scholar
• Kapoor S. (2016). Tumor growth attenuating effect of Celastrol in systemic malignancies. Int J Cancer 139:1431.
   PubMed Web of Science ®Google Scholar
• Kim DY, Park JW, Ro JY. (2009). Celastrol reduces airway hypersensitivity and lung tissue remodeling via regulating the production of MMP-2/9 in mouse allergic asthma model. Am J Respir Crit Care 179:A4226–27.
   PubMed Web of Science ®Google Scholar
• Klein CA. (2009). Parallel progression of primary tumours and metastases. Nat Rev Cancer 9:302–12.
   PubMed Web of Science ®Google Scholar
• Liu X, Cheng BL, Meng TT, et al. (2016). Synthesis and biological application of BKT-140 peptide modified polymer micelles for treating tumor metastasis with an enhanced cell internalization. Polym Chem 7:1375–86.
   Web of Science ®Google Scholar
• Lu WZ, Jia GF, Zhao C, et al. (2015). Celastrol induces apoptosis of HT29 cells through inhibiting miR-21 regulation of Bcl-2 expression. Lat Am J Pharm 34:390–6.
   Google Scholar
• Matsumoto Y, Sakurai H, Kogashiwa Y, Saito K. (2016). Cetuximab inhibits migration, invasion, metastasis and epithelial-mesenchymal transition but not proliferation via GEP100Arf6-AMAP1 pathway in head and neck squamous cell carcinoma. Cancer Res 76:1605–6.
   Web of Science ®Google Scholar
• Meylan E, Dooley AL, Feldser DM, et al. (2009). Requirement for NF-kappa B signalling in a mouse model of lung adenocarcinoma. Nature 462:104–7.
   PubMed Web of Science ®Google Scholar
• Mi CL, Shi H, Ma J, et al. (2014). Celastrol induces the apoptosis of breast cancer cells and inhibits their invasion via downregulation of MMP-9. Oncol Rep 32:2527–32.
   PubMed Web of Science ®Google Scholar
• Mo R, Jiang T, DiSanto R, et al. (2014). ATP-triggered anticancer drug delivery. Nat Commun 5:3364.
   PubMed Web of Science ®Google Scholar
• Mousa SA, Bergh JJ, Dier E, et al. (2008). Tetraiodothyroacetic acid, a small molecule integrin ligand, blocks angiogenesis induced by vascular endothelial growth factor and basic fibroblast growth factor. Angiogenesis 11:183–90.
   PubMed Web of Science ®Google Scholar
• Nacev A, Kim SH, Rodriguez-Canales J, et al. (2011). A dynamic magnetic shift method to increase nanoparticle concentration in cancer metastases: a feasibility study using simulations on autopsy specimens. Int J Nanomedicine 6:2907–23.
   PubMed Web of Science ®Google Scholar
• O’Flanagan CH, Rossi EL, McDonell SB, et al. (2017). Metabolic reprogramming underlies metastatic potential in an obesity-responsive murine model of metastatic triple negative breast cancer. NPJ Breast Cancer 3:26.
   PubMed Web of Science ®Google Scholar
• Pang X, Yi Z, Zhang X, et al. (2009). Acetyl-11-keto-beta-boswellic acid inhibits prostate tumor growth by suppressing vascular endothelial growth factor receptor 2-mediated angiogenesis. Cancer Res 69:5893–900.
   PubMed Web of Science ®Google Scholar
• Pang XF, Yi ZF, Zhang J, et al. (2010). Celastrol suppresses angiogenesis-mediated tumor growth through inhibition of AKT/mammalian target of rapamycin pathway. Cancer Res 70:1951–9.
   PubMed Web of Science ®Google Scholar
• Park BK, Zhang HL, Zeng QH, et al. (2007). NF-kappa B in breast cancer cells promotes osteolytic bone metastasis by inducing osteoclastogenesis via GM-CSF. Nat Med 13:62–9.
   PubMed Web of Science ®Google Scholar
• Perkins ND. (2007). Integrating cell-signalling pathways with NF-kappa B and IKK function . Nat Rev Mol Cell Biol 8:49–62.
   PubMed Web of Science ®Google Scholar
• Rebbaa A, Chu F, Davis FB, et al. (2008). Novel function of the thyroid hormone analog tetraiodothyroacetic acid: a cancer chemosensitizing and anti-cancer agent. Angiogenesis 11:269–76.
   PubMed Web of Science ®Google Scholar
• Sakamoto K, Maeda S. (2010). Targeting NF-kappa B for colorectal cancer. Expert Opin Ther Targets 14:593–601.
   PubMed Web of Science ®Google Scholar
• Schnell O, Krebs B, Wagner E, et al. (2008). Expression of integrin alphavbeta3 in gliomas correlates with tumor grade and is not restricted to tumor vasculature. Brain Pathol 18:378–86.
   PubMed Web of Science ®Google Scholar
• Sethi G, Ahn KS, Pandey MK, Aggarwal BB. (2013). Celastrol, a novel triterpene, potentiates TNF-induced apoptosis and suppresses invasion of tumor cells by inhibiting NF-kappa B-regulated gene products and TAK1-mediated NF-kappa B activation. Blood 122:1327.
   Web of Science ®Google Scholar
• Sethi G, Sung B, Aggarwal BB. (2008). Nuclear factor-kB activation: from bench to bedside. Exp Biol Med 233:21–31.
   PubMed Web of Science ®Google Scholar
• Sha M, Ye J, Zhang LX, et al. (2014). Celastrol induces apoptosis of gastric cancer cells by miR-21 inhibiting PI3K/Akt-NF-kappa B signaling pathway. Pharmacology 93:39–46.
   PubMed Web of Science ®Google Scholar
• Tan Y, Zhu Zhao Y, Wen Y, et al. (2017). Mitochondrial alkaline pH-responsive drug release mediated by Celastrol loaded glycolipid-like micelles for cancer therapy. Biomaterials 154:169–81.
   PubMed Web of Science ®Google Scholar
• Ullah I, Muralidharan K, Alkodsi G, et al. (2017). Evolutionary analyses of matched primary and metastatic breast cancer reveal both linear and parallel progression with lack of axillary lymph node involvement. Cancer Res 77:P6-01-04.
   Web of Science ®Google Scholar
• Valastyan S, Weinberg RA. (2011). Tumor metastasis: molecular insights and evolving paradigms. Cell 147:275–292.
   PubMed Web of Science ®Google Scholar
• Wang Y, Du H, Zhai G. (2014). Recent advances in active hepatic targeting drug delivery system. Curr Drug Targets 15:573–99.
   PubMed Web of Science ®Google Scholar
• Woodhouse EC, Chuaqui RF, Liotta LA. (1997). General mechanisms of metastasis. Cancer 80:1529–1537.
   PubMed Web of Science ®Google Scholar
• Wu Y, Deng J, Rychahou PG, et al. (2009). Stabilization of snail by NF-kappa B is required for inflammation-induced cell migration and invasion. Cancer Cell 15:416–28.
   PubMed Web of Science ®Google Scholar
• Yang HL, Korivi M, Lin MW, et al. (2015). Anti-angiogenic properties of coenzyme Q(0) through downregulation of MMP-9/NF-kappa B and upregulation of HO-1 signaling in TNF-alpha-activated human endothelial cells. Biochem Pharmacol 98:144–156.
   PubMed Web of Science ®Google Scholar
• Zheng L, Fu YY, Zhuang LH, et al. (2014). Simultaneous NF-kappa B inhibition and E-cadherin upregulation mediate mutually synergistic anticancer activity of celastrol and SAHA in vitro and in vivo. Int J Cancer 135:1721–1732.
   PubMed Web of Science ®Google Scholar
• Zhou LL, Lin ZX, Fung KP, et al. (2011). Celastrol-induced apoptosis in human HaCaT keratinocytes involves the inhibition of NF-kappa B activity. Eur J Pharmacol 670:399–408.
   PubMed Web of Science ®Google Scholar
• Zhu L, Kate P, Torchilin VP. (2012). Matrix metalloprotease 2-responsive multifunctional liposomal nanocarrier for enhanced tumor targeting. Acs Nano 6:3491–3498.
   PubMed Web of Science ®Google Scholar